Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2
Jess M. Cunnick(Moffitt Cancer Center), Jie Wu(University of Oklahoma Health Sciences Center)
Cited by 167
Related Papers
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma
|British Journal of Cancer|2015|81
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib
|npj Precision Oncology|2021|49
PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
|Molecular Medicine Reports|2018|17
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors
|Molecular Cancer Therapeutics|2023|14
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy
|RSC Medicinal Chemistry|2025|1